GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theravance Biopharma Inc (FRA:0TB) » Definitions » Other Gross PPE

Theravance Biopharma (FRA:0TB) Other Gross PPE : €40.56 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Theravance Biopharma Other Gross PPE?

Theravance Biopharma's Other Gross PPE for the quarter that ended in Mar. 2024 was €40.56 Mil.

Theravance Biopharma's quarterly Other Gross PPE increased from Sep. 2023 (€43.91 Mil) to Dec. 2023 (€57.36 Mil) but then declined from Dec. 2023 (€57.36 Mil) to Mar. 2024 (€40.56 Mil).

Theravance Biopharma's annual Other Gross PPE increased from Dec. 2021 (€74.19 Mil) to Dec. 2022 (€75.67 Mil) but then declined from Dec. 2022 (€75.67 Mil) to Dec. 2023 (€57.36 Mil).


Theravance Biopharma Other Gross PPE Historical Data

The historical data trend for Theravance Biopharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theravance Biopharma Other Gross PPE Chart

Theravance Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.38 79.97 74.19 75.67 57.36

Theravance Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.92 44.31 43.91 57.36 40.56

Theravance Biopharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Theravance Biopharma (FRA:0TB) Business Description

Traded in Other Exchanges
Address
Ugland House, South Church Street, George Town, PO Box 309, Grand Cayman, CYM, KY1-1104
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Theravance Biopharma (FRA:0TB) Headlines

No Headlines